Acasti Pharma (ACST) Short Interest Ratio & Short Volume → The Gold Grab of the Century (From Colonial Metals) (Ad) Free ACST Stock Alerts $2.95 -0.01 (-0.34%) (As of 05/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Acasti Pharma Short Interest DataCurrent Short Volume3,800 sharesPrevious Short Volume1,400 sharesChange Vs. Previous Month+171.43%Dollar Volume Sold Short$12,768.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares9,400,000 sharesFloat Size6,740,000 sharesShort Percent of Float0.06%Today's Trading Volume11,882 sharesAverage Trading Volume24,657 sharesToday's Volume Vs. Average48% Short Selling Acasti Pharma ? Sign up to receive the latest short interest report for Acasti Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatACST Short Interest Over TimeACST Days to Cover Over TimeACST Percentage of Float Shorted Over Time Ad InvestorPlaceThe 2024 crypto bull run has already started — don’t get left behindOne of the first ever crypto millionaires who bought Bitcoin when it was trading for just $5 in 2011 is back with his next huge prediction. A newly approved government regulation is set to flood trillions of dollars into the crypto markets, leading to the FINAL crypto bull run. One of the "Kings of Crypto" has revealed five tiny cryptos that could soar over the course of 2024. Potentially resulting in gains as big as 10X, 50X, or even 100X over the next 12 months.Get His #1 Coin For 2024 FREE By Clicking Here Acasti Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,800 shares $12,768.00 +171.4%0.1%0.1 $3.36 3/31/20241,400 shares $4,795.00 -78.8%0.0%0 $3.43 3/15/20246,600 shares $22,506.00 -71.6%0.1%0.2 $3.41 2/29/202423,200 shares $77,488.00 +105.3%0.3%0.8 $3.34 2/15/202411,300 shares $34,578.00 -52.1%0.2%0.4 $3.06 1/31/202423,600 shares $59,472.00 +20.4%0.4%1.1 $2.52 Get the Latest News and Ratings for ACST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/202419,600 shares $52,528.00 -73.5%0.3%0.9 $2.68 12/31/202373,900 shares $213,571.00 +23.8%1.1%3.5 $2.89 12/15/202359,700 shares $128,355.00 -22.3%0.9%1.1 $2.15 11/30/202376,800 shares $166,656.00 -16.4%1.3%1.5 $2.17 11/15/202391,900 shares $200,342.00 -10.0%1.5%1.9 $2.18 10/31/2023102,100 shares $240,956.00 -8.8%2.1%2 $2.36 10/15/2023112,000 shares $291,200.00 -48.9%2.4%2.2 $2.60 9/30/2023219,200 shares $610,143.20 +1,401.4%4.6%3.9 $2.78 9/15/202314,600 shares $29,054.00 -22.8%0.3%0.3 $1.99 8/31/202318,900 shares $39,690.00 -19.6%0.4%0.7 $2.10 8/15/202323,500 shares $52,875.00 +27.7%0.4%0.9 $2.25 7/31/202318,400 shares $47,472.00 +10.2%0.3%0.7 $2.58 7/15/202316,700 shares $41,750.00 -46.1%0.2%0.7 $2.50 6/30/202331,000 shares $97,668.60 -89.7%N/A1.5 $3.15 6/15/2023301,400 shares $173,274.86 -28.0%0.8%4.8 $0.57 5/31/2023418,300 shares $225,882.00 -19.5%1.1%7 $0.54 5/15/2023519,500 shares $252,165.30 +1.5%1.3%8.6 $0.49 4/30/2023511,900 shares $232,402.60 -2.4%1.3%8.4 $0.45 4/15/2023524,300 shares $246,316.14 +3.6%1.3%6.9 $0.47 3/31/2023506,300 shares $232,847.37 +5.4%1.3%5.4 $0.46 3/15/2023480,600 shares $211,464.00 +58.1%1.4%2.4 $0.44 2/28/2023303,900 shares $155,596.80 +41.1%0.9%1.4 $0.51 2/15/2023215,400 shares $137,877.54 +31.9%0.6%1 $0.64 1/31/2023163,300 shares $115,959.33 -18.6%0.5%0.7 $0.71 1/15/2023200,700 shares $142,497.00 -50.0%0.6%0.9 $0.71 12/30/2022401,100 shares $200,951.10 +537.7%1.2%2 $0.50 12/15/202262,900 shares $22,165.96 +103.6%0.2%0.5 $0.35 11/30/202230,900 shares $12,940.92 -42.2%0.1%0.4 $0.42 11/15/202253,500 shares $26,599.29 -41.7%0.2%0.8 $0.50 10/31/202291,700 shares $51,902.20 -13.9%0.3%1.5 $0.57 10/15/2022106,500 shares $58,575.00 -22.2%0.3%1.6 $0.55 9/30/2022136,900 shares $79,881.15 -4.3%0.4%2 $0.58 9/15/2022143,000 shares $112,398.00 -7.1%0.4%2 $0.79 8/31/2022154,000 shares $125,294.40 -32.2%0.4%2 $0.81Controversial CEO explains new way to amass wealth (Ad)There's no shortage of controversial CEOs in America today... From Elon Musk... to Disney's Bob Iger... to JP Morgan's Jamie Dimon... But only one controversial CEO that I know of is willing to show you exactly how and why he cut his annual salary to $1...Don't miss Porter's brand-new presentation on this subject ACST Short Interest - Frequently Asked Questions What is Acasti Pharma's current short interest? Short interest is the volume of Acasti Pharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 3,800 shares of ACST short. 0.06% of Acasti Pharma's shares are currently sold short. Learn More on Acasti Pharma's current short interest. What is a good short interest percentage for Acasti Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.06% of Acasti Pharma's floating shares are currently sold short. Is Acasti Pharma's short interest increasing or decreasing? Acasti Pharma saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 3,800 shares, an increase of 171.4% from the previous total of 1,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acasti Pharma's float size? Acasti Pharma currently has issued a total of 9,400,000 shares. Some of Acasti Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acasti Pharma currently has a public float of 6,740,000 shares. How does Acasti Pharma's short interest compare to its competitors? 0.06% of Acasti Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acasti Pharma: Unity Biotechnology, Inc. (1.99%), Forte Biosciences, Inc. (0.09%), NRx Pharmaceuticals, Inc. (6.69%), Sensei Biotherapeutics, Inc. (0.50%), Iterum Therapeutics plc (7.50%), Lipocine Inc. (5.41%), Bullfrog AI Holdings, Inc. (5.49%), Aprea Therapeutics, Inc. (2.01%), Biora Therapeutics, Inc. (4.33%), Lumos Pharma, Inc. (5.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Acasti Pharma stock? Short selling ACST is an investing strategy that aims to generate trading profit from Acasti Pharma as its price is falling. ACST shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acasti Pharma? A short squeeze for Acasti Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACST, which in turn drives the price of the stock up even further. How often is Acasti Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACST, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: UBX Short Interest Data FBRX Short Interest Data NRXP Short Interest Data SNSE Short Interest Data ITRM Short Interest Data LPCN Short Interest Data BFRG Short Interest Data APRE Short Interest Data BIOR Short Interest Data LUMO Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACST) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin Analytics